Refractory Plasma Cell Myeloma
Showing NaN - NaN of 5
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Refractory Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma Trial in United States (ixazomib citrate, dexamethasone,
Active, not recruiting
- Refractory Plasma Cell Myeloma
- Recurrent Plasma Cell Myeloma
- ixazomib citrate
- +2 more
-
Scottsdale, Arizona
- +4 more
Mar 28, 2022
Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in
Recruiting
- Myelodysplastic Syndrome
- +16 more
- Computed Tomography
- +6 more
-
Scottsdale, Arizona
- +2 more
Feb 3, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Scottsdale, Jacksonville, Rochester (Cyclophosphamide,
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Cyclophosphamide
- +4 more
-
Scottsdale, Arizona
- +2 more
Aug 29, 2019
Refractory Plasma Cell Myeloma Trial in Scottsdale (Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Laboratory Biomarker
Terminated
- Refractory Plasma Cell Myeloma
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation
- Laboratory Biomarker Analysis
-
Scottsdale, ArizonaMayo Clinic in Arizona
Sep 14, 2017